Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy in a trachomatous population.

I R Schwab, E Nassar, R Malaty

    Archives of Ophthalmology (Chicago, Ill. : 1960)
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Autoantibody profiling to predict response to the anti-PD-1 therapy, pembrolizumab, in rare tumors.

    ESMO open·2025
    Same author

    The evolution of eyes: major steps. The Keeler lecture 2017: centenary of Keeler Ltd.

    Eye (London, England)·2017
    Same author

    Mango dermatitis and its relationship to poison ivy hypersensitivity.

    Annals of allergy·2010
    Same author

    The relation of hypersensitiveness to poison ivy and to the pure ingredients in cashew nut shell liquid and related substances.

    Industrial medicine & surgery·2010
    Same author

    A quantitative study of the relation of synthetic 3-pentadecyl catechol to hypersensitiveness to Rhus toxicodendron (poison ivy) as shown by the patch test.

    The Journal of allergy·2010
    Same author

    3-n-pentadecylcatechol.

    Journal of the American Chemical Society·2010

    Blindness in leprosy patients is often caused by corneal opacity, phthisis bulbi, and cataract. Early treatment and surgical interventions can help prevent or restore vision in affected individuals.

    Area of Science:

    • Ophthalmology
    • Infectious Diseases
    • Public Health

    Background:

    • Leprosy significantly impacts vision, with a notable percentage of patients experiencing severe visual impairment.
    • Common causes of blindness in leprosy patients include corneal opacity, phthisis bulbi, and cataract, collectively accounting for a high burden of visual loss.
    • The interplay between leprosy and trachoma exacerbates blinding corneal conditions through various mechanisms.

    Purpose of the Study:

    • To investigate the prevalence and causes of visual impairment in leprosy patients.
    • To explore the relationship between leprosy types and the severity of trachoma-related ocular complications.
    • To identify effective interventions for preventing and restoring vision in leprosy patients.

    Main Methods:

    Related Experiment Videos

  • A study was conducted on 133 patients at an Egyptian leprosy hospital.
  • Visual acuity was assessed, and causes of blindness were identified.
  • The frequency of specific ocular conditions was compared between leprosy patient groups.

    • Main Results:

    • 17% of patients had visual acuity below 3/60.
    • Corneal opacity, phthisis bulbi, and cataract were the primary causes of blindness.
    • Patients with lepromatous leprosy showed less conjunctival scarring from trachoma compared to tuberculoid leprosy patients, potentially due to immune differences.

    Conclusions:

    • Blindness in leprosy patients is multifactorial, with corneal issues and cataracts being predominant.
    • Understanding the immune response in leprosy is crucial for explaining variations in trachoma complications.
    • A combination of medical and surgical interventions is vital for managing visual impairment in leprosy patients.